Oruka Therapeutics, Inc. Due to Related Parties
Oruka Therapeutics, Inc. (ORKA) had Due to Related Parties of $324.00 thousand as of 2023-03-31, per its 10-Q filed 2023-04-24.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrentAndNoncurrent · last filed 2023-04-24
- 2023-03-31: Due to Related Parties $324.00K.
- 2022-12-31: Due to Related Parties $216.00K.
| Period end | Due to Related Parties |
|---|---|
| 2023-03-31 | $324.00K 10-Q · filed 2023-04-24 |
| 2022-12-31 | $216.00K 10-Q · filed 2023-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |